Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma

Gockel, Ines; Schimanski, Carl C.; Heinrich, Christian; Wehler, T.; Frerichs, K.; Drescher, Daniel; von Langsdorff, Christian; Domeyer, Mario; Biesterfeld, Stefan; Galle, Peter R.; Junginger, Theodor; Moehler, Markus
January 2006
BMC Cancer;2006, Vol. 6, p290
Academic Journal
Background: Prognosis of esophageal cancer is poor despite curative surgery. The chemokine receptor CXCR4 has been proposed to distinctly contribute to tumor growth, dissemination and local immune escape in a limited number of malignancies. The aim of our study was to evaluate the role of CXCR4 in tumor spread of esophageal cancer with a differentiated view of the two predominant histologic types - squamous cell and adenocarcinoma. Methods: Esophageal cancer tissue samples were obtained from 102 consecutive patients undergoing esophageal resection for cancer with curative intent. The LSAB+ System was used to detect the protein CXCR4. Tumor samples were classified into two groups based on the homogeneous staining intensity. A cut-off between CXCR4w (= weak expression) and CXCR4s (= strong expression) was set at 1.5 (grouped 0 - 1.5 versus 2.0 - 3). Long-term survival rates were calculated using life tables and the Kaplan-Meier method. Using the Cox's proportional hazards analysis, a model of survival prediction was established. Results: The overall expression rate for CXCR4 in esophageal squamous cell carcinoma was 94.1%. Subdividing these samples, CXCR4w was found in 54.9% and CXCR4s in 45.1%. In adenocarcinoma, an overall expression rate of 89.1% was detected with a weak intensitiy in 71.7% compared to strong staining in 29.3% (p = 0.066 squamous cell versus adenocarcinoma). The Cox's proportional hazards analysis identified the pM-category with a hazard ratio (HR) of 1.860 (95% CI: 1.014-3.414) (p = 0.045), the histologic tumor type (HR: 0.334; 95% CI: 0.180-0.618) (p = 0.0001) and the operative approach (transthoracic > transhiatal esophageal resection) (HR: 0.546; 95% CI: 0.324-0.920) (p = 0.023) as independent factors with a possible influence on the long-term prognosis in patients with esophageal carcinoma, whereas CXCR4 expression was statistically not significant (>0.05). Conclusion: Expression of the chemokine receptor CXCR4 in esophageal cancer is of major relevance in both histologic entities - squamous cell and adenocarcinoma. Though with lack of statistical significance, strong CXCR4 expression revealed a poorer long-term prognosis following curative esophagectomy in both histologic subtypes. Thus, the exact biological functions of CXCR4 in terms of tumor dissemination of esophageal cancer is yet undetermined. Inhibition of esophageal cancer progression by CXCR4 antagonists might be a promising therapeutic option in the future.


Related Articles

  • PROCLAMATIONS: 2012-95 Esophageal Cancer Awareness Month.  // Illinois Register;3/30/2012, Vol. 36 Issue 13, p4968 

    The article presents information on the proclamation on the Esophageal Cancer Awareness Month declared by the government of the state of Illinois. The purpose of the proclamation is to awareness amongst the citizens of the U.S. on the esophageal cancer that is of two types esophageal...

  • Treatment of more advanced cancer. Lundell, L. // Journal of the Royal College of Surgeons of Edinburgh;Aug2000, Vol. 45 Issue 4, p270 

    Describes the treatment of more advanced oesophageal cancer. Incidence of squamous cell carcinoma and adenocarcinoma of the esophagus; Shift of the biological behavior of oesophageal cancer; Immature differentiation and greater nodal involvement; Combination of chemo- and radiotherapy and...

  • Esophageal Cancer. Thomas Brunner; Rolf Sauer // Strahlentherapie und Onkologie;Jan2008, Vol. 184 Issue 1, p15 

    Purpose:  To present the results of a prospective phase II study in esophageal carcinoma. Patients and Methods:  Patients received single doses of 1.8 Gy up to 27 Gy, then concomitant boost to a total of 50.4 Gy (PTV2 [planning target volume], single dose 1.8...

  • Investigation of the association of esophageal carcinoma with human papillomaviruses. Kamath; Wu; Heitmiller; Daniel; Shah // Diseases of the Esophagus;Jun2000, Vol. 13 Issue 2, p122 

    The role of human papillomavirus (HPV) in esophageal cancers was evaluated in patients seen at Johns Hopkins University Hospital. Frozen esophageal tumor tissues from 22 cases with squamous cell carcinoma (SCC) and 24 cases with adenocarcinoma (AC), diagnosed between 1988 and 1998, were assayed...

  • Squamous cell carcinoma and adenocarcinoma of the lower third of the esophagus and gastric cardia: similarities and differences. Alexandrou, A.; Davis, P. A.; Law, S.; Murthy, S.; Whooley, B. P.; Wong, J. // Diseases of the Esophagus;Dec2002, Vol. 15 Issue 4, p290 

    SUMMARY. Squamous cell carcinoma (SCC) and adenocarcinoma (ADC) of the lower esophagus and gastric cardia were compared in their clinical features and long-term prognosis. Two hundred and ninety-five patients with SCC and 263 with ADC were reviewed. Resectability rates for SCC and ADC were 74.2%...

  • Changing Pattern of Esophageal Cancer Incidence in New Mexico: A 30-Year Evaluation. Vega, Kenneth J.; Jamal, M. Mazen; Wiggins, Charles L. // Digestive Diseases & Sciences;Jun2010, Vol. 55 Issue 6, p1622 

    The incidence of esophageal adenocarcinoma has increased over the last 30 years, especially in non-Hispanic whites (nHw). Recent work indicates an increase in Hispanic Americans (HA). It is important to understand the effect of ethnicity on cancer occurrence over a prolonged interval. We...

  • The Lack of Association between Adenocarcinoma of the Esophagus and Gastric Surgery: A Retrospective Study. Birgisson, Sigurbjörn; Rice, Thomas W.; Easley, Kirk A.; Richter, Joel E. // American Journal of Gastroenterology;Feb1997, Vol. 92 Issue 2, p216 

    Background: The cause of the rapid increase in the incidence of adenocarcinoma of the esophagus since the 1970s is unknown. Objective: To test the hypothesis that duodenogastroesophageal reflux causes adenocarcinoma of the esophagus by comparing the frequency of gastric surgery (a human model of...

  • Oesophageal cancer: exploring controversies overview of experts' opinions of Austria, Germany, France, Netherlands and Switzerland. Putora, Paul Martin; Bedenne, Laurent; Budach, Wilfried; Eisterer, Wolfgang; Van Der Gaast, Ate; Jäger, Robert; Jan Van Lanschot, J. B.; Mariette, Christophe; Schnider, Annelies; Stahl, Michael; Ruhstaller, Thomas // Radiation Oncology;2015, Vol. 10 Issue 1, p1 

    Background: Oesophageal carcinoma is a rare disease with often dismal prognosis. Despite multiple trials addressing specific issues, currently, many questions in management remain unanswered. This work aimed to specifically address areas in the management of oesophageal cancer where high level...

  • Rising Incidence of Adenocarcinoma of the Esophagus and Gastric Cardia. Blot, William J.; Devesa, Susan S.; Kneller, Robert W.; Fraumeni, Joseph F. // JAMA: Journal of the American Medical Association;3/13/91, Vol. 265 Issue 10, p1287 

    Examines the rising incidence of patients with adenocarcinoma of the esophagus and gastric cardia in the U.S. from 1976 to 1987. Trends in squamous cell carcinomas of the esophagus; Histologic categories of esophageal cancers; Patterns of esophageal and gastric cardia adenocarcinomas.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics